Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

NCT06541574 is registered in ClinicalTrials.gov with Cincinnati Eye Institute, Southwest Ohio as lead sponsor.

NCT NCT06541574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06541574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
Lead sponsor
Cincinnati Eye Institute, Southwest Ohio
Phase
Phase 2
Overall status
Recruiting
Start date
March 1, 2024
Completion date
June 30, 2026
Enrollment
860 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative vitreoretinopathy, rhegmatogenous retinal detachment